adMare has helped build 36 companies, of which 25 are still active. These companies have attracted $2.4 billion of risk capital, have a combined value of $5.7 billion, and have created around 1,000 jobs in Canada.
The Accelerator Companies include both current and past participants in adMare Accelerator, a testament to our impact across various stages of company development.
Telescope Therapeutics offers an iPSC-based platform to help optimize clinical trials “in-a-dish” for drug discovery. We also have proprietary drug discovery programs for cardiovascular and renal disease.